Mont. Admin. R. 24.168.911 - OCULAR THERAPEUTIC APPROVED DRUGS

Current through Register Vol. 6, March 25, 2022

(1) The board hereby approves the following drugs for the use in ocular treatment limited to the anterior segment of the eye and adnexa:
(a) anti-infective agents, including:
(i) antibiotic;
(ii) antiviral;
(iii) antifungal; and
(iv) antiparasitic;
(b) autoimmune agents, including:
(i) antiallergy;
(ii) antihistamines;
(iii) decongestants;
(iv) mast cell stabilizers; and
(v) antianaphylaxis;
(c) analgesics;
(d) anti-inflammatory agents;
(e) antiglaucoma agents;
(f) hyperosmotic agents;
(g) autonomic agents; and
(h) over the counter agents.

Notes

Mont. Admin. R. 24.168.911
NEW, 1987 MAR p. 2234, Eff. 12/11/87; AMD, 1990 MAR p. 2176, Eff. 12/14/90; AMD, 1994 MAR p. 153, Eff. 1/28/94; AMD, 1999 MAR p. 2760, Eff. 12/3/99; TRANS, from Commerce, 2003 MAR p. 2083; AMD, 2007 MAR p. 296, Eff. 3/9/07.

37-1-131, 37-10-202, MCA; IMP, 37-10-101, 37-10-103, 37-10-304, MCA;

The following state regulations pages link to this page.



State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.